RECTICEL 10.480 € (+0,96 %) SIPEF 100.400 € (-0,99 %) SOLVAY 26.180 € (-9,29 %) AB INBEV 68.060 € (-3,27 %) ONWARD MEDICAL 2.680 € (-0,74 %) KINEPOLIS GROUP 30.600 € (+0,82 %) UCB 237.300 € (+0,55 %) BARCO 9.175 € (-0,16 %) KBC 117.100 € (+0,90 %) BIOTALYS 2.910 € (-2,35 %) AEDIFICA 72.000 € (-1,03 %) BREDERODE 102.400 € (-0,58 %) AGEAS 67.300 € (0,00 %) SOFINA 222.000 € (-1,07 %) ARGENX SE 700.000 € (+1,69 %) SYENSQO 57.050 € (-2,98 %) D'IETEREN GROUP 184.900 € (+0,49 %) VAN DE VELDE 31.200 € (-5,17 %) UMICORE 21.480 € (+3,37 %) DECEUNINCK 2.060 € (0,00 %) ECONOCOM GROUP 1.410 € (+0,71 %) WDP 22.580 € (-0,18 %) MELEXIS 76.450 € (-0,33 %) MONTEA 70.300 € (-0,71 %) ACKERMANS V.HAAREN 296.200 € (-0,07 %) KBC ANCORA 81.000 € (+1,25 %) XIOR 27.850 € (+0,54 %) GBL 82.000 € (-0,24 %) NYXOAH 2.705 € (-0,37 %) TUBIZE-FIN 202.200 € (-0,10 %) WHAT'S COOKING GP 143.500 € (0,00 %) CIE BOIS SAUVAGE 326.500 € (+0,15 %) CMB.TECH 12.500 € (-1,11 %) ELIA GROUP 136.600 € (-1,94 %) FAGRON 24.800 € (-0,20 %) SHURGARD 26.150 € (+0,19 %) RETAIL ESTATES 67.600 € (-0,73 %) TESSENDERLO 21.900 € (+0,92 %) VGP 90.600 € (+0,33 %) BEKAERT 44.150 € (+0,34 %) PROXIMUS 6.585 € (-0,30 %) GIMV 48.400 € (-0,41 %) AZELIS GROUP 10.630 € (-1,57 %) OPTION 6.020 € (-1,63 %) CAMPINE 224.000 € (-1,75 %) EXMAR 10.800 € (-0,46 %) TITAN S.A. 51.200 € (+3,64 %) CELYAD ONCOLOGY 0.310 € (-2,52 %) ONTEX GROUP 2.900 € (+0,17 %) COFINIMMO 84.850 € (-0,64 %) HOME INVEST BE. 19.320 € (-0,31 %) DEME GROUP 205.000 € (+0,74 %) BPOST 1.666 € (-2,00 %) LOTUS BAKERIES 10 860.000 € (+1,12 %) FLUXYS BELGIUM D 22.100 € (-2,21 %) KEYWARE TECH. 0.970 € (0,00 %) ATENOR 1.695 € (+0,89 %) CARE PROPERTY INV. 13.160 € (+0,46 %) WERELDHAVE BELGIUM 53.600 € (+0,37 %) VIOHALCO 17.580 € (+1,27 %)
OPMOBILITY 15.650 € (+1,03 %)
LOUIS HACHETTE 1.598 € (-3,15 %)
FDJ UNITED 22.980 € (0,00 %)
VIRIDIEN 118.000 € (-1,17 %)
EMEIS 15.380 € (+0,59 %)
CVC CAPITAL 13.590 € (+0,37 %)
KLEA HOLDING 0.186 € (-0,96 %)
ODYSSEE TECHNO 21.700 € (+1,88 %)
STIF 51.000 € (-0,97 %)
J.MARTINS,SGPS 20.580 € (+3,78 %)
SOITEC 152.350 € (+3,75 %)
UMG 19.215 € (+0,34 %)
AVANTIUM 8.370 € (-5,32 %)
SCHNEIDER ELECTRIC 285.650 € (+1,04 %)
PROSUS 42.490 € (+1,46 %)
SAINT GOBAIN 81.700 € (+1,82 %)
KALRAY 8.500 € (+0,95 %)
AIRBUS 189.560 € (+0,56 %)
HEINEKEN 66.660 € (-0,09 %)
CSG 16.474 € (-3,41 %)
AIR FRANCE -KLM 10.595 € (+2,81 %)
SOCIETE GENERALE 71.050 € (+1,50 %)
AIR LIQUIDE 178.220 € (-1,14 %)
ADYEN 961.100 € (+0,37 %)
CAPGEMINI 104.100 € (-0,81 %)
ASML HOLDING 1 328.400 € (+1,79 %)
DASSAULT SYSTEMES 19.695 € (-0,38 %)
HERMES INTL 1 716.000 € (+2,66 %)
ING GROEP N.V. 25.865 € (+1,31 %)
VOPAK 44.340 € (+0,45 %)
BNP PARIBAS ACT.A 94.180 € (+0,82 %)
SONAE 1.956 € (-0,31 %)
GTT 207.600 € (-1,42 %)
PHARMING GROUP 1.160 € (-16,85 %)
L'OREAL 374.050 € (+0,17 %)
STMICROELECTRONICS 48.720 € (+0,45 %)
ALSTOM 17.715 € (+0,77 %)
GALP ENERGIA-NOM 18.965 € (-1,71 %)
BIOSYNEX 0.810 € (+10,05 %)
THALES 240.600 € (-0,17 %)
NANOBIOTIX 36.120 € (+4,09 %)
SANOFI 73.600 € (-1,39 %)
TOTALENERGIES 75.820 € (-1,21 %)
LEGRAND 165.200 € (+3,19 %)
EDP 4.389 € (+0,87 %)
MEDINCELL 26.580 € (+0,23 %)
KPN KON 4.570 € (-0,80 %)
COFACE 16.300 € (+0,80 %)
ACCOR 45.640 € (+2,33 %)
RENAULT 31.320 € (+2,02 %)
LVMH 484.950 € (+2,31 %)
HAFFNER ENERGY 0.120 € (+10,09 %)
ADOCIA 5.215 € (+8,56 %)
CHRISTIAN DIOR 456.400 € (+2,06 %)
EUROFINS SCIENT. 59.860 € (-0,23 %)
Vusion 124.200 € (-0,16 %)
SAFRAN 300.850 € (+1,40 %)
FORVIA 10.730 € (+2,39 %)
AXA 41.720 € (-0,19 %)
REXEL 38.830 € (+1,01 %) News Réglementées
|
15/04/2026 16:37
Original-Research: Shelly Group SE (von Montega AG): BuyOriginal-Research: Shelly Group SE - from Montega AG Classification of Montega AG to Shelly Group SE
Preliminary Q1 Results Surprise to the Upside Shelly reported a strong start to the year with preliminary Q1 figures, delivering revenue growth above our expectations in what was anticipated to be a more challenging quarter. In addition, the company further strengthened its cash position, underlining the improving financial profile. [Table] Top line development better than expected despite timing effects: Revenue in Q1 reached EUR 33.4m, slightly above our estimate (MONe: EUR 32.3m), corresponding to a growth rate of 26.0% yoy. This performance is particularly noteworthy given the previously communicated timing effects related to product launches. As a reminder, several key new products were delayed by a few months, leading to a stronger focus on selling existing product lines to distributors in Q4 2025. This resulted in temporarily elevated inventory levels at distributors, which we had expected to weigh on order activity in Q1. Against this backdrop, the reported growth exceeds expectations and supports our view that underlying demand remains strong. We continue to expect a further acceleration in growth momentum over the course of the year as new product launches gain traction. Improved cash position and focus on working capital: Shelly reported a noticeable increase in its cash position, primarily driven by improved accounts payable. At the same time, management has initiated measures to address the elevated level of trade receivables, which had been a key concern among investors following the year-end figures. According to the company, receivables are expected to normalize over the coming quarters. A successful reduction in receivables would have a particularly positive impact on free cash flow generation. For FY26, we currently forecast a free cash flow of EUR 19.7m, which still assumes a moderate increase in receivables, albeit below the revenue growth rate. SDAX inclusion enhances visibility and liquidity: Since April 10, Shelly has been included in the SDAX, marking the first listing of a Bulgarian company in the index. This milestone reflects the company’s strong operational development in recent years and the increasing relevance of the stock in the capital markets. The index inclusion should further improve trading liquidity and enhance visibility among institutional investors. Conclusion: Overall, the Q1 figures provide a positive signal, demonstrating resilient demand despite temporary headwinds from product timing effects. Combined with the improving cash profile and increased capital market visibility, we see Shelly well positioned to deliver accelerating growth over the remainder of the year and reaffirm our buy rating and price target of EUR 79.00. +++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Bitte lesen Sie unseren RISIKOHINWEIS / HAFTUNGSAUSSCHLUSS unter http://www.montega.de +++ Über Montega: Die Montega AG ist eine innovative Investment-Banking-Boutique mit klarem Fokus auf den Mittelstand und agiert als Plattformanbieter für den Austausch zwischen börsennotierten Unternehmen und institutionellen Investoren. Montega erstellt hochwertiges Equity Research, veranstaltet vielfältige Kapitalmarktevents im In- und Ausland und bietet eine umfassende Unterstützung bei Eigen- und Fremdkapitalfinanzierungen. Die Mission: Emittenten und Investoren zusammenbringen und für Transparenz im Börsenumfeld sorgen. Dabei konzentriert sich Montega auf jene Marktteilnehmer, deren Sprache die Mittelstandsexperten am besten beherrschen: Small- und MidCaps auf der einen sowie Vermögensverwalter, Family Offices und Investment-Boutiquen mit einem Anlagefokus im Nebenwertebereich auf der anderen Seite. You can download the research here: Factsheet Contact for questions: Montega AG - Equity Research Tel.: +49 (0)40 41111 37-80 Web: www.montega.de E-Mail: info@montega.de LinkedIn: https://www.linkedin.com/company/montega-ag The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2309178 15.04.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière